Log in
E-mail
Password
Show password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
New member
Sign up for FREE
New customer
Discover our services
Settings
Settings
Dynamic quotes 
OFFON

INFANT BACTERIAL THERAPEUTICS AB (PUBL)

(IBT B)
  Report
SummaryQuotesChartsNewsCalendarCompanyFinancials 
SummaryMost relevantAll NewsOther languagesPress ReleasesOfficial PublicationsSector news

Infant Bacterial Therapeutics AB Announces Recruitment of the Smallest Infants in the Connection Study Paused

08/25/2021 | 06:50am EST

IBT started to recruit infants in Strata A (weight of 500g-749g) in The Connection Study on April 29, 2021. Today, 68 infants have been recruited to the group. In accordance with the study protocol and clinical observations, enrolment of infants to Strata A has been paused awaiting a safety review by the Data Monitoring Committee. Subjects already randomized will continue treatment as per protocol, and enrolment of subjects into Strata B (750g-1000g) will continue. IBT is awaiting advice from the DMC before taking any decision regarding further recruitment of infants in Strata A. The DMC is expected to give their opinion in September this year.


ę S&P Capital IQ 2021
All news about INFANT BACTERIAL THERAPEUTICS AB (PUBL)
11/01Infant Bacterial Therapeutics AB Announces Composition of Nomination Committee
CI
11/01Nomination Committee appointed for the 2022 Annual General Meeting (AGM) in Infant Bact..
AQ
10/29Nomination Committee appointed for the 2022 Annual General Meeting (AGM) in Infant Bact..
AQ
10/29Infant Bacterial Therapeutics AB (publ), Interim report January 1-September 30, 2021
AQ
10/29Infant Bacterial Therapeutics AB Reports Earnings Results for the Third Quarter and Nin..
CI
09/30INFANT BACTERIAL THERAPEUTICS : Next recruitment milestone reached in IBT's Phase III Stud..
AQ
09/30Infant Bacterial Therapeutics Announces Next Recruitment Milestone Reached in Ibt’S Pha..
CI
09/23INFANT BACTERIAL THERAPEUTICS : IBT - After safety review The Connection study is now agai..
AQ
09/22INFANT BACTERIAL THERAPEUTICS : After safety review The Connection study is now again open..
AQ
09/22Infant Bacterial Therapeutics AB Announces After Safety Review the Connection Study Is ..
CI
More news
Financials
Sales 2020 - - -
Net income 2020 -72,0 M -7,89 M -7,89 M
Net cash 2020 423 M 46,4 M 46,4 M
P/E ratio 2020 -17,5x
Yield 2020 -
Capitalization 757 M 83,1 M 82,9 M
EV / Sales 2019 -
EV / Sales 2020 -
Nbr of Employees 8
Free-Float 89,2%
Chart INFANT BACTERIAL THERAPEUTICS AB (PUBL)
Duration : Period :
Infant Bacterial Therapeutics AB (publ) Technical Analysis Chart | MarketScreener
Full-screen chart
Technical analysis trends INFANT BACTERIAL THERAPEUTICS AB (PUBL)
Short TermMid-TermLong Term
TrendsBearishBearishBearish
Income Statement Evolution
Managers and Directors
Staffan Str÷mberg Chief Executive Officer
Marie-Louise Alamaa Chief Financial Officer
Peter Michael Rothschild Chairman
Eamonn Connolly Chief Scientific Officer
Jonas Rastad Chief Medical Officer